Vimarsana
Biggest News Aggregation in the World

Nasdaq Vrna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Vrna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Vrna Today - Breaking & Trending Today

China Universal Asset Management Co. Ltd. Trims Stake in Verona Pharma plc (NASDAQ:VRNA) - Vimarsana News

China Universal Asset Management Co. Ltd. Trims Stake in Verona Pharma plc (NASDAQ:VRNA)

China Universal Asset Management Co. Ltd. cut its holdings in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 73.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 14,878 shares of the company’s stock after selling 40,806 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Verona Pharma were worth […]

China Universal Asset Management Co. Ltd. Has $296,000 Position in Verona Pharma plc (NASDAQ:VRNA) - Vimarsana News

China Universal Asset Management Co. Ltd. Has $296,000 Position in Verona Pharma plc (NASDAQ:VRNA)

China Universal Asset Management Co. Ltd. lessened its stake in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 73.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 14,878 shares of the company’s stock after selling 40,806 shares during the quarter. China Universal […]

Verona Pharma (NASDAQ:VRNA) Shares Up 4.9% - Vimarsana News

Verona Pharma (NASDAQ:VRNA) Shares Up 4.9%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price shot up 4.9% on Thursday . The stock traded as high as $17.15 and last traded at $17.02. 285,724 shares were traded during trading, a decline of 43% from the average session volume of 502,863 shares. The stock had previously closed at $16.23. Analyst Ratings […]

Source: wkrb13.com
Verona Pharma (NASDAQ:VRNA) Earns Buy Rating from HC Wainwright - Vimarsana News

Verona Pharma (NASDAQ:VRNA) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $32.00 price objective on the stock. Separately, Wedbush reiterated an outperform rating and issued a $33.00 target price on shares of Verona Pharma in a research report on […]

Source: wkrb13.com
Verona Pharma (NASDAQ:VRNA) Stock Price Down 8.9% - Vimarsana News

Verona Pharma (NASDAQ:VRNA) Stock Price Down 8.9%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report) shares were down 8.9% on Tuesday . The stock traded as low as $17.36 and last traded at $18.43. Approximately 160,862 shares changed hands during trading, a decline of 74% from the average daily volume of 609,346 shares. The stock had previously closed at $20.24. Analyst Upgrades […]

Source: wkrb13.com